Hemangiosarcoma (cutaneous)

Cutaneous hemangiosarcoma is a malignant cancer arising from the cells that line blood vessels in the skin and subcutaneous tissues of dogs. Unlike the more aggressive visceral form that affects internal organs such as the spleen and heart, cutaneous hemangiosarcoma develops in the dermal and hypodermal layers of the skin. This form of cancer represents approximately fifteen to twenty percent of all hemangiosarcoma cases diagnosed in dogs and carries a more favorable prognosis when caught early and treated appropriately. The condition is particularly associated with chronic sun exposure, making it more common in dogs living in sunny climates or those who spend significant time outdoors without protection.

The development of cutaneous hemangiosarcoma is closely linked to ultraviolet radiation damage to the endothelial cells that form blood vessel walls. When these cells undergo malignant transformation, they begin to proliferate uncontrollably, forming tumors that can appear as raised, red, or purple masses on the skin. The tumors are often found on areas with sparse hair coverage or light pigmentation, including the ventral abdomen, inner thighs, and prepuce in male dogs. Because these tumors arise from blood vessels, they tend to be highly vascular and may bleed easily when traumatized or as they grow larger.

The impact of cutaneous hemangiosarcoma on a dog's health depends significantly on the tumor's location, size, and whether it has spread to other tissues. Superficial dermal tumors confined to the skin's surface layer generally have the best prognosis, with surgical excision often providing excellent outcomes. However, tumors that extend into the subcutaneous tissue or hypodermal layer carry a higher risk of metastasis to regional lymph nodes, lungs, and other organs. Early detection is crucial because the prognosis worsens significantly once the cancer spreads beyond the primary site.

Treatment for cutaneous hemangiosarcoma typically involves wide surgical excision of the tumor along with surrounding healthy tissue to ensure complete removal of cancer cells. In cases where complete excision is achieved and the tumor was confined to the dermis, many dogs experience long-term survival without recurrence. However, more invasive tumors may require additional treatments such as chemotherapy or radiation therapy. Veterinary oncologists play a vital role in determining the most appropriate treatment plan based on tumor staging, location, and the individual dog's overall health status. Regular veterinary examinations are essential for early detection, particularly in predisposed breeds and dogs with significant sun exposure history.

The primary cause of cutaneous hemangiosarcoma in dogs is chronic exposure to ultraviolet radiation from sunlight. The UV rays damage the DNA within endothelial cells that line blood vessels in the skin, leading to mutations that can eventually result in malignant transformation. This process typically occurs over many years, which is why cutaneous hemangiosarcoma is predominantly diagnosed in middle-aged to older dogs who have accumulated significant sun exposure throughout their lives. The relationship between sun exposure and this cancer is so strong that it is sometimes referred to as solar-induced or actinic hemangiosarcoma when it occurs in sun-damaged skin.

Genetic and hereditary factors play a significant role in determining which dogs are most susceptible to developing cutaneous hemangiosarcoma. Dogs with light-colored or white coats and pink or lightly pigmented skin have significantly reduced natural protection against UV radiation compared to darker-pigmented dogs. The pigment melanin acts as a natural sunscreen, absorbing harmful UV rays before they can penetrate deeper into the skin and damage cellular DNA. Dogs lacking adequate melanin in their skin are essentially unprotected against the cumulative effects of sun exposure, making them much more vulnerable to developing sun-induced skin cancers including hemangiosarcoma.

Environmental and lifestyle factors beyond general sun exposure contribute to the development of this cancer. Dogs who live in geographic regions with intense sunlight, high altitudes, or reduced cloud cover face increased UV exposure throughout their lives. Similarly, dogs who spend extended periods outdoors, particularly during peak sun hours between ten in the morning and four in the afternoon, accumulate more UV damage than dogs with limited outdoor access. Certain activities such as lying on their backs in sunny spots or sunbathing on concrete or other reflective surfaces can increase exposure to vulnerable areas like the ventral abdomen and inner thighs.

Risk factors for cutaneous hemangiosarcoma extend beyond sun exposure and pigmentation. Age is a significant factor, with most cases diagnosed in dogs between eight and thirteen years old after years of accumulated cellular damage. Dogs with pre-existing sun damage, including solar dermatitis or actinic keratosis, are at elevated risk for developing hemangiosarcoma in affected areas. Additionally, immunocompromised dogs or those receiving immunosuppressive medications may have reduced ability to detect and eliminate abnormal cells before they become cancerous.

The mechanism by which cutaneous hemangiosarcoma develops involves a multi-step process of cellular damage and genetic mutation. Repeated UV exposure causes direct DNA damage in endothelial cells, leading to mutations in tumor suppressor genes and oncogenes that normally regulate cell growth and division. When these regulatory mechanisms fail, affected cells begin to divide uncontrollably while losing their normal function and structure. The resulting tumor mass consists of abnormal blood vessel tissue that forms irregular vascular channels and may hemorrhage spontaneously. As the tumor progresses, cancer cells may acquire additional mutations that enable them to invade surrounding tissues and eventually metastasize to distant organs through the bloodstream or lymphatic system.

Early warning signs of cutaneous hemangiosarcoma are often subtle and may be mistaken for benign skin conditions or minor injuries. Owners may first notice small red or purple spots on their dog's skin, particularly in areas with sparse hair coverage or light pigmentation. These early lesions may resemble bruises, blood blisters, or minor skin irritations, leading many owners to dismiss them as insignificant. The spots may appear to come and go or change slightly in appearance, which can further delay recognition of the underlying problem. Because dogs do not typically show pain or discomfort in the early stages, there are few behavioral cues to alert owners to the developing cancer.

The most common symptoms of cutaneous hemangiosarcoma involve visible changes to the skin that become more pronounced as tumors grow. Affected dogs develop raised, nodular masses that range in color from dark red to purple or black, reflecting the blood-filled nature of these vascular tumors. The tumors may have a smooth or irregular surface and can vary in size from a few millimeters to several centimeters in diameter. Multiple tumors may be present simultaneously, particularly in dogs with extensive sun damage. The surrounding skin may appear abnormal, showing signs of chronic sun damage including thickening, discoloration, or loss of elasticity.

Behavioral changes associated with cutaneous hemangiosarcoma may become apparent as the condition progresses. Dogs may begin licking, scratching, or paying unusual attention to areas where tumors are developing, even before masses are obviously visible. Some dogs become reluctant to lie in certain positions or on particular surfaces if pressure on tumors causes discomfort. Changes in activity level, appetite, or general demeanor may occur, particularly if the cancer is causing pain or if the dog has developed systemic illness from advanced disease. Owners who know their dogs well often sense that something is wrong before visible symptoms become obvious.

Physical signs of cutaneous hemangiosarcoma include the characteristic appearance of the tumors themselves and changes in the surrounding tissue. The tumors are typically soft to moderately firm and may feel fluid-filled due to their vascular nature. They are often located on the ventral abdomen, prepuce, inner thighs, or other areas of thin, lightly pigmented skin. Tumors may ulcerate through the skin surface, appearing as open sores that fail to heal. The surrounding skin frequently shows evidence of chronic sun damage, including areas of redness, scaling, or abnormal texture that may contain additional smaller lesions.

Symptom progression in cutaneous hemangiosarcoma follows a pattern that reflects the biological behavior of the tumor. Early-stage tumors remain localized and may grow slowly over weeks to months. As tumors enlarge, they become more prone to hemorrhage, sometimes bleeding profusely from minor trauma or spontaneously without apparent cause. Bleeding episodes may result in noticeable blood on bedding, floors, or the dog's coat. With advanced disease, tumors may become necrotic and infected, producing foul-smelling discharge. Dogs with metastatic disease may develop additional symptoms related to affected organs, including respiratory difficulty if the lungs are involved.

Emergency symptoms requiring immediate veterinary attention include sudden, severe hemorrhage from skin tumors that does not stop with gentle pressure. Signs of internal bleeding, such as pale gums, weakness, collapse, or a distended abdomen, indicate that the cancer may have spread to internal organs and caused life-threatening hemorrhage. Difficulty breathing, persistent coughing, or sudden onset of lethargy and depression may suggest pulmonary metastasis. Any rapidly growing mass, particularly one that has ulcerated or is actively bleeding, warrants urgent evaluation. Dogs showing signs of shock, including rapid heart rate, weak pulse, and cold extremities, require emergency stabilization and care.

The diagnostic process for cutaneous hemangiosarcoma begins with a thorough physical examination by a veterinarian who will carefully assess all visible skin lesions and palpate for additional masses. The veterinarian will take a detailed history including information about the dog's sun exposure, living environment, and how long any skin changes have been present. Particular attention is paid to the location, size, color, and consistency of any tumors, as well as whether they have bled or changed over time. The veterinarian will also examine regional lymph nodes for any enlargement that might suggest cancer spread and assess the dog's overall health status.

Diagnostic testing for suspected cutaneous hemangiosarcoma typically begins with cytology or tissue sampling to confirm the diagnosis. Fine needle aspiration may be attempted, though hemangiosarcomas often yield primarily blood due to their vascular nature, making cytologic diagnosis challenging. Surgical biopsy with histopathology is usually necessary to definitively diagnose hemangiosarcoma and differentiate it from other vascular tumors. The biopsy provides critical information about tumor grade, depth of invasion, and completeness of surgical margins if the mass was removed. Blood work including a complete blood count and chemistry panel helps assess overall health and may reveal anemia if significant bleeding has occurred.

Differential diagnosis is important because several other conditions can resemble cutaneous hemangiosarcoma in appearance. Hemangiomas are benign vascular tumors that may look similar but behave very differently and carry an excellent prognosis. Other skin tumors including melanomas, mast cell tumors, and histiocytomas can sometimes have a similar appearance. Non-cancerous conditions such as hematomas from trauma, blood blisters, or even spider angiomas may also mimic hemangiosarcoma. Accurate diagnosis through histopathology is essential because treatment approaches and prognoses differ significantly among these conditions.

Once hemangiosarcoma is confirmed, staging is performed to determine the extent of disease and guide treatment planning. This typically includes thoracic radiographs to evaluate the lungs for metastasis, as the lungs are a common site for spread of this cancer. Abdominal ultrasound may be recommended to assess the spleen, liver, and other abdominal organs for evidence of visceral involvement. Advanced imaging such as CT scanning provides more detailed information about tumor extent and metastatic disease when available. The combination of histopathology results and staging information allows the veterinary team to classify the cancer according to established staging systems, which helps predict prognosis and determine the most appropriate treatment approach for each individual case.

Emergency and immediate treatment for cutaneous hemangiosarcoma focuses on stabilizing dogs who present with active hemorrhage or complications from their tumors. Bleeding from vascular tumors can sometimes be controlled with direct pressure and bandaging, though surgical intervention may be necessary for severe or persistent hemorrhage. Dogs who have lost significant blood may require intravenous fluid therapy to maintain blood pressure and oxygen delivery to tissues. Blood transfusions may be necessary for dogs with severe anemia resulting from acute or chronic blood loss. Pain management and supportive care help keep dogs comfortable while the veterinary team develops a comprehensive treatment plan.

Medical management of cutaneous hemangiosarcoma primarily involves chemotherapy, which may be used as adjuvant therapy following surgery or as palliative treatment for advanced disease. Doxorubicin-based chemotherapy protocols are commonly employed and have shown some efficacy in delaying tumor recurrence and metastasis. Metronomic chemotherapy using low doses of oral medications such as cyclophosphamide combined with non-steroidal anti-inflammatory drugs represents an alternative approach that some owners find more manageable. While chemotherapy rarely cures hemangiosarcoma, it can extend survival time and improve quality of life in many cases. Medical management also includes pain control, nutritional support, and treatment of any secondary complications.

Surgical excision remains the primary treatment for localized cutaneous hemangiosarcoma and offers the best chance for long-term control of the disease. Wide surgical margins are essential to remove all cancer cells and reduce the risk of local recurrence. The surgeon typically removes at least two to three centimeters of apparently normal tissue surrounding the visible tumor. For tumors on the trunk, this usually poses few challenges, but tumors in certain locations may require creative surgical approaches or reconstructive techniques. Histopathology of the excised tissue determines whether the margins are clean, which significantly impacts prognosis and may influence recommendations for additional therapy.

Supportive care plays a vital role in the overall treatment of dogs with cutaneous hemangiosarcoma. Nutritional support ensures dogs maintain adequate body condition throughout treatment, as cancer and its treatment can affect appetite and metabolism. Pain management using appropriate analgesic medications improves quality of life and helps dogs remain comfortable and active. Wound care following surgery helps ensure proper healing and reduces the risk of complications. Regular monitoring and follow-up appointments allow the veterinary team to assess treatment response, detect any recurrence early, and adjust the care plan as needed.

Alternative and complementary treatments may be considered as part of a comprehensive approach to managing cutaneous hemangiosarcoma. Some veterinary oncologists incorporate immunotherapy or targeted molecular therapies as part of clinical trials or off-label treatment protocols. Supplements such as omega-3 fatty acids and certain antioxidants may provide supportive benefits, though their direct anti-cancer effects are not proven. Physical rehabilitation and acupuncture may help maintain mobility and comfort, particularly in older dogs or those recovering from extensive surgery. These approaches should be discussed with the veterinary oncology team to ensure they complement rather than interfere with primary treatment.

Treatment decisions for cutaneous hemangiosarcoma depend on multiple factors that must be carefully weighed by the veterinary team and the dog's owners. The stage of the disease at diagnosis significantly impacts both the available treatment options and the expected outcomes. The tumor's location affects surgical options and the feasibility of achieving clean margins. The dog's overall health status, age, and concurrent medical conditions influence both treatment tolerance and life expectancy independent of the cancer. Financial considerations are also important, as cancer treatment can be costly, and owners must make decisions that align with their resources while still providing appropriate care for their dogs.

Recovery from surgical treatment of cutaneous hemangiosarcoma follows a timeline that varies based on the extent of the surgery and the individual dog's healing capacity. Most dogs recover from routine tumor excision within two to three weeks, with initial restriction of activity giving way to gradual return to normal routines. The surgical site must be kept clean and monitored for signs of infection, excessive swelling, or wound breakdown. Dogs typically wear an Elizabethan collar or surgical suit to prevent them from licking or chewing at their incision. Sutures or staples are usually removed ten to fourteen days after surgery once adequate healing has occurred.

Post-treatment care following surgery for cutaneous hemangiosarcoma involves careful attention to wound healing and activity management. Exercise restriction during the initial healing period helps prevent complications such as seroma formation, dehiscence, or excessive scarring. Medications prescribed may include antibiotics to prevent infection, pain relievers for comfort, and anti-inflammatory drugs to reduce swelling. Follow-up appointments allow the veterinarian to assess healing progress and address any concerns. If chemotherapy is part of the treatment plan, it typically begins two to three weeks after surgery once the dog has recovered from the procedure and sutures have been removed.

Prognosis for dogs with cutaneous hemangiosarcoma depends heavily on the stage of disease at diagnosis and the completeness of surgical excision. Dogs with tumors confined to the dermis that are completely excised with clean margins have the best prognosis, with median survival times often exceeding two years and some dogs achieving cure. Subcutaneous tumors carry a more guarded prognosis, with higher rates of local recurrence and metastasis reducing median survival to approximately six to twelve months. Dogs with evidence of metastasis at diagnosis have a poor prognosis, with survival typically measured in months even with treatment. Individual factors including the dog's overall health and response to therapy also influence outcomes.

Long-term outlook for dogs who have been treated for cutaneous hemangiosarcoma requires ongoing vigilance and regular monitoring. Recurrence of the cancer, either at the original site or in new locations, is possible and may occur months to years after initial treatment. Regular veterinary examinations every three to four months during the first two years help detect any recurrence at the earliest possible stage. Thoracic radiographs may be repeated periodically to monitor for pulmonary metastasis. Dogs who remain cancer-free for two to three years following treatment have an excellent chance of long-term survival, though some late recurrences can occur. Quality of life remains a central focus, with the goal of maximizing comfortable, active time with family.

Primary prevention of cutaneous hemangiosarcoma focuses on minimizing ultraviolet radiation exposure, particularly for dogs at highest risk due to their light-colored coats and poorly pigmented skin. Limiting outdoor time during peak sun hours between ten in the morning and four in the afternoon significantly reduces UV exposure. Providing shaded areas in the yard and encouraging dogs to rest in protected spots helps limit sun damage. Indoor time during the hottest, brightest parts of the day protects vulnerable skin while still allowing dogs to enjoy outdoor activities during safer hours. These lifestyle modifications are especially important for dogs living in sunny climates or at high altitudes where UV exposure is more intense.

Responsible breeding practices can help reduce the incidence of cutaneous hemangiosarcoma in predisposed breeds over time. Breeders of light-colored dogs should be aware of the cancer risks associated with minimal skin pigmentation and consider this factor in breeding decisions. While it is not practical to eliminate all lightly pigmented dogs from breeding programs, awareness of the issue encourages breeders to prioritize dogs with better natural sun protection when possible. Puppy buyers should be educated about the increased cancer risks associated with certain coat colors and the importance of sun protection throughout the dog's life.

Nutritional strategies may provide some supportive benefit in reducing cancer risk, though no specific diet has been proven to prevent hemangiosarcoma. Feeding a balanced, high-quality diet supports overall health and immune function, which may help the body identify and eliminate abnormal cells before they become cancerous. Some evidence suggests that diets rich in omega-3 fatty acids and antioxidants may have protective effects against cancer development, though research specifically addressing hemangiosarcoma is limited. Maintaining a healthy body weight reduces chronic inflammation and oxidative stress that may contribute to cancer development. Avoiding excessive supplementation with unproven cancer-prevention products is recommended, as some may interfere with beneficial cellular processes.

Regular veterinary care and health maintenance form an essential foundation for preventing the most serious consequences of cutaneous hemangiosarcoma through early detection. Annual or semi-annual wellness examinations provide opportunities for veterinarians to examine the skin thoroughly and identify suspicious lesions before they progress to advanced cancer. Owners should learn to perform regular at-home skin checks, particularly examining areas of sparse hair coverage and light pigmentation. Any new growths, color changes, or non-healing sores should be promptly evaluated by a veterinarian. Dogs with significant sun damage or pre-cancerous changes may benefit from more frequent monitoring.

Early intervention strategies focus on identifying and addressing precancerous changes before they progress to invasive cancer. Solar dermatitis and actinic keratosis represent early sun damage that increases the risk of developing hemangiosarcoma and should prompt enhanced sun protection measures. Small, superficial vascular lesions in sun-damaged skin may be removed prophylactically to prevent progression. Regular monitoring of dogs with known sun damage allows for early detection of any malignant changes. Working closely with a veterinarian to develop an appropriate surveillance and prevention plan based on the individual dog's risk factors provides the best opportunity to prevent advanced disease or catch cancer at its most treatable stage.

Daily management of a dog diagnosed with cutaneous hemangiosarcoma involves establishing routines that support both treatment efficacy and quality of life. Medication administration must be consistent and properly timed, whether the dog is receiving chemotherapy, pain medication, or other therapeutic agents. Monitoring the skin for any new lesions or changes in existing tumors becomes part of the daily routine, with owners learning to document observations for discussion with the veterinary team. Activity levels should be appropriate for the individual dog's condition, balancing the benefits of exercise and mental stimulation against the need to avoid trauma to tumor sites. Regular gentle grooming helps maintain coat health and provides opportunities to examine the skin thoroughly.

Home environment modifications may be necessary to ensure the safety and comfort of dogs living with cutaneous hemangiosarcoma. Sun protection remains critically important and may require changes to the dog's normal routines and living spaces. Window films that block UV radiation can reduce exposure during indoor time, particularly for dogs who enjoy lying in sunny spots. Outdoor areas should be evaluated and modified to provide adequate shade, or outdoor time should be limited to early morning and evening hours. Protective clothing such as UV-blocking bodysuits or T-shirts can shield vulnerable skin during necessary outdoor activities. Soft, comfortable bedding helps prevent trauma to tumors and supports overall comfort.

Maintaining quality of life is a central focus when living with a dog who has been diagnosed with cutaneous hemangiosarcoma. Dogs should be encouraged to participate in activities they enjoy as long as they are physically able to do so comfortably. Mental stimulation through training, puzzle toys, and social interaction helps maintain emotional well-being even when physical activities must be modified. Spending quality time together strengthens the bond between dog and owner and provides comfort to both during a difficult period. Adapting favorite activities to accommodate any limitations allows dogs to continue experiencing joy and engagement with life.

Ongoing monitoring and veterinary care are essential components of living with cutaneous hemangiosarcoma. Regular follow-up appointments allow the veterinary team to assess the dog's response to treatment, detect any signs of disease progression, and adjust the management plan as needed. Between appointments, owners should watch for any concerning changes including new tumors, signs of bleeding, changes in energy or appetite, or respiratory symptoms that might indicate metastasis. Maintaining open communication with the veterinary team ensures that problems are addressed promptly and that treatment decisions are made collaboratively. Documentation of observations, medications, and any changes helps ensure continuity of care.

Caregiver support is an important but often overlooked aspect of managing a dog's cancer diagnosis. Caring for a dog with cancer can be emotionally and financially demanding, and owners should not hesitate to seek support. Veterinary oncology teams can provide guidance, answer questions, and help owners understand what to expect throughout the course of the disease. Online communities and support groups connect owners of dogs with cancer and provide opportunities to share experiences and advice. Being realistic about financial constraints and treatment goals helps owners make decisions that are right for their individual situations. Prioritizing quality time and the human-animal bond, regardless of treatment choices, ensures that dogs and their families make the most of their time together.

Certain breeds face significantly elevated risk for developing cutaneous hemangiosarcoma, primarily those with light-colored coats and minimal skin pigmentation. Whippets and Italian Greyhounds are among the breeds most commonly affected, with their thin coats and areas of exposed, lightly pigmented skin making them particularly vulnerable to UV damage. Pit Bull Terriers and American Staffordshire Terriers, especially those with white or piebald coloring, also show increased susceptibility. Dalmatians, Boxers with white markings, Bull Terriers, and other breeds with significant areas of light-colored coat are predisposed. The common factor among these breeds is reduced melanin production in portions of their skin, leaving them with inadequate natural protection against ultraviolet radiation.

Moderate-risk breeds include any dogs with significant white markings or light pigmentation, regardless of breed or mixed heritage. Basset Hounds, Beagles, and other short-coated breeds with white areas face increased risk in those unpigmented regions. Golden Retrievers, Labrador Retrievers, and other breeds with light undercarriage pigmentation may develop tumors in those vulnerable areas. Mixed breed dogs with any significant white coloring should be considered at increased risk and monitored accordingly. Generally, any dog whose belly, inner thighs, or other sparsely haired areas appear pink rather than darkly pigmented may be susceptible to sun-induced skin cancers including hemangiosarcoma.

Screening recommendations for breeds at risk of cutaneous hemangiosarcoma emphasize regular veterinary skin examinations and owner vigilance. Owners of predisposed breeds should perform frequent at-home skin checks, paying particular attention to areas of light pigmentation and sparse hair coverage. Any new spots, color changes, or growths should be promptly evaluated by a veterinarian rather than watched at home. Veterinarians may recommend more frequent wellness examinations for high-risk dogs, with thorough skin assessment as a standard component of each visit. Preventive counseling about sun protection should begin when dogs are young to minimize cumulative UV damage over the lifetime. Breeders of at-risk breeds have a responsibility to inform puppy buyers about the increased cancer risks associated with light-colored dogs.

Cutaneous hemangiosarcoma commonly co-occurs with other forms of sun damage and solar-induced skin conditions. Solar dermatitis, characterized by reddened, inflamed, and thickened skin in sun-exposed areas, frequently precedes the development of hemangiosarcoma and indicates cumulative UV damage. Actinic keratosis, which appears as rough, scaly patches on sun-damaged skin, represents a precancerous change that may progress to various skin cancers. Squamous cell carcinoma, another UV-induced malignancy, may develop in dogs with extensive sun damage and can occur alongside hemangiosarcoma. Dogs diagnosed with any sun-induced skin condition should be monitored closely for the development of additional lesions including hemangiosarcoma.

Several conditions may present with symptoms similar to cutaneous hemangiosarcoma and must be differentiated through proper diagnostic testing. Hemangiomas are benign vascular tumors that can appear identical to hemangiosarcomas on visual examination but carry an excellent prognosis and require only simple excision. Other skin tumors including melanomas, mast cell tumors, and soft tissue sarcomas may have similar appearances and require histopathology for accurate diagnosis. Hematomas resulting from trauma can mimic the appearance of vascular tumors but resolve on their own without treatment. Accurate differentiation between these conditions is essential because treatment approaches and prognoses differ dramatically.

Potential complications of cutaneous hemangiosarcoma include both local and systemic consequences of the disease. Local complications include tumor ulceration with secondary bacterial infection, chronic bleeding that can lead to anemia, and pain or discomfort from growing masses. Metastasis to the lungs represents the most common systemic complication, causing respiratory symptoms such as coughing, labored breathing, and exercise intolerance. Spread to other organs including the spleen, liver, and lymph nodes may occur, particularly with subcutaneous or advanced tumors. Complications should prompt re-evaluation of the treatment plan and may necessitate changes in the management approach or discussions about prognosis and quality of life considerations.